Michael Mason

Overview

Michael Mason received an average of $2M in total compensation, including $400K in salary, at Karyopharm Therapeutics from 2019 to 2021.

Source: SEC filings on April 8, 2022 and April 7, 2021.

Related executives

We found ten more executives who work or worked at Karyopharm Therapeutics.

Richard Paulson

Karyopharm Therapeutics

Chief Executive Officer

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

Jatin Shah

Karyopharm Therapeutics

Chief Medical Officer

Ran Frenkel

Karyopharm Therapeutics

Executive Vice President, Chief Development Officer

Christopher Primiano

Karyopharm Therapeutics

General Counsel

Anand Varadan

Karyopharm Therapeutics

Executive Vice President, Chief Commercial Officer

Michael MSM

Karyopharm Therapeutics

Chief Financial Officer

News

You may also like